Pfizer Inc. (NYSE:PFE)
The Company gained 0.98% and finished at $36.12. The daily volume was measured at 17.79 million shares. The 52-week high of the share price is $36.46 and the 52-week low is $28.25. The company has a market cap of $222.14 billion. The stock has a P/E ratio of 29.61.Its latest closing price has a distance of 3.52% from SMA20 and is 5.64 up than SMA50. The stock currently has Price to Sales (P/S) value of 4.36 where Price to Book (P/B) value stands at 3.52.
PFE is currently showing 6.15 billion shares outstanding as compared with the 6.06 billion total shares float.
The Stock has its Beta Value of 0.85 and ATR (Average True Range) of 0.49. The Weekly and Monthly Volatility of the stock are 1.34% and 1.41% respectively. The weekly performance of the company stands at 2.58 percent while it’s 1-month and 3-month returns are 2.47 percent and 12.13 percent.
By looking at Pfizer Inc. (PFE) YTD (year to date) performance, the stock shows Positive value of 14.03%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is appreciating.
The High price target of the company’s Share is at $54 based on the calculations and analysis of 21 brokers. According to the analysts, the company has the Low Price target of $33 whereas, the Mean Target is estimated by the brokers is $38.67.
For an overview on Recommendation Trends, 4 Analysts assigned the stock as Strong Buy. 10 said it’s a Buy, 9 assigned Hold rating where 0 stated the stock as Underperform and 0 marked the stock as Sell.
While Looking at the Earnings Estimates of the company, The Average Earnings Estimate for the Current Fiscal quarter is measured as $0.62 by 15 analysts. They are also projecting the Low EPS estimate as $0.57 as compared to the Higher EPS estimate of $0.69.
Now when we talk about Revenue Estimate for the current Fiscal Quarter, Average Revenue Estimate of Pfizer Inc. (PFE) is projected as $12.94 Billion where Low Revenue estimate and High Revenue Estimates are $12.49 Billion and $13.32 Billion respectively by 12 analysts.